ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,301 | 61.25897 | 1 | female | 0 | 13 | 128 | Lung Cancer | Cancer | 1 | 19 | under $11k | 0 | 13,490 | 8,014.7656 | null | 7 | black | 29.398438 | 19 | 0.401978 | 0.104996 | 1 | 0 | 0 | metastatic | 0.4 | 0.5 | dnr after sadm | 1 | 87 | null | 110 | 10 | 36.69531 | 404.75 | 3 | null | 0.599976 | 131 | 7.449219 | null | null | null | 1 | null | SIP>=30 | 1.1669 |
2,302 | 68.52295 | 1 | male | 0 | 9 | 17 | Lung Cancer | Cancer | 1 | 7 | null | 0 | 9,748 | 6,052.6523 | null | 15 | white | 18.699219 | 12 | 0.662964 | 0.360962 | 1 | 0 | 0 | metastatic | 0.5 | 0.02 | dnr after sadm | 1 | 97 | 5.399414 | 100 | 20 | 36.09375 | null | 3.599609 | null | 1 | 144 | null | null | null | null | null | 7 | <2 mo. follow-up | 7 |
2,303 | 86.64795 | 1 | male | 0 | 8 | 17 | COPD | COPD/CHF/Cirrhosis | 3 | 20 | >$50k | 0 | 8,987 | 5,409.3164 | null | 8.5 | white | 19.199219 | 28 | 0.748901 | 0.60498 | 1 | 0 | 0 | no | 0.6 | 0.4 | dnr after sadm | 2 | 90 | 13.398438 | 80 | 30 | 36.09375 | 204 | 3.699707 | 0.599976 | 1.699951 | 146 | 7.449219 | null | null | null | 1 | 5 | <2 mo. follow-up | 5 |
2,304 | 67.43298 | 1 | male | 0 | 20 | 414 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | null | 0 | 29,192 | 17,898.7812 | null | 10 | white | 23.699219 | 36 | 0.771973 | 0.636963 | 5 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 20 | 53 | 7.899414 | 60 | 22 | 35.89844 | 532 | null | null | 1.599854 | 136 | 7.449219 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,305 | 85.06195 | 1 | female | 1 | 14 | 14 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 38,155 | 26,735.8125 | null | 30.333328 | white | 30.398438 | 38 | 0.507935 | 0.306946 | 1 | 0 | 0 | no | 0.9 | 0.7 | dnr after sadm | 13 | 68 | 12.599609 | 120 | 8 | 38.69531 | 163.3125 | 2.5 | 0.5 | 0.599976 | 142 | 7.479492 | null | null | null | 6 | null | <2 mo. follow-up | 4.527397 |
2,306 | 55.42499 | 1 | male | 0 | 6 | 105 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 7,515 | 4,379.293 | null | 17 | black | 19.898438 | 10 | 0.672974 | 0.373962 | 1 | 0 | 0 | metastatic | 0.6 | 0.1 | no dnr | 6 | 100 | 4.099609 | 100 | 20 | 36.09375 | null | 3.299805 | null | 1 | 144 | null | null | null | null | 0 | 0 | null | 0 |
2,307 | 68.63794 | 1 | male | 0 | 5 | 196 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 6,801 | 4,078.2344 | null | 17 | white | 22.296875 | 33 | 0.779907 | 0.648926 | 1 | 0 | 0 | yes | 0.9 | 0.6 | no dnr | 5 | 53 | 15.898438 | 70 | 20 | 35.59375 | null | 3.699707 | null | 1.399902 | 140 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.108887 |
2,308 | 68.03595 | 1 | male | 0 | 18 | 118 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 27,335 | 13,538.8984 | null | 21 | white | 26.5 | 33 | 0.612915 | 0.507935 | 2 | 0 | 0 | metastatic | 0.9 | 0.8 | dnr after sadm | 7 | 57 | 5.099609 | 82 | 28 | 38.29688 | 98.32812 | null | null | 0.799927 | 139 | 7.469727 | null | null | null | 7 | 5 | no(M2 and SIP pres) | 5 |
2,309 | 62.198 | 1 | female | 0 | 32 | 1,258 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 0 | 62,019 | 41,464.5938 | null | 20.25 | white | 37.195313 | 41 | 0.462952 | 0.343994 | 8 | 1 | 0 | no | 0.75 | 0.5 | no dnr | 32 | 45 | 20.898438 | 132 | 8 | 41.29688 | 162.5 | 2.699707 | null | 1 | 139 | 7.509766 | null | null | null | null | null | SIP>=30 | 3.121094 |
2,310 | 87.72296 | 1 | female | 0 | 13 | 390 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | under $11k | 9 | 16,386 | 7,860.3008 | null | 8.5 | white | 17.097656 | 26 | 0.790894 | 0.7229 | 2 | 1 | 0 | no | 0.8 | 0.6 | dnr after sadm | 5 | 61 | 10.298828 | 58 | 16 | 37.79688 | null | null | null | 0.699951 | 137 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,311 | 62.24197 | 1 | male | 0 | 6 | 42 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 9,470 | 5,086.2266 | null | 8 | black | 12.099609 | 9 | 0.887939 | 0.812988 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 6 | 83 | 5.5 | 80 | 20 | 36.09375 | 316 | 3.199707 | 0.699951 | 1 | 139 | 7.429688 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
2,312 | 66.80396 | 1 | female | 0 | 8 | 385 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 9,066 | 5,457.0195 | null | 7 | white | 12.699219 | 13 | 0.780884 | 0.542969 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 8 | 66 | 6.099609 | 104 | 24 | 37.39844 | null | 3.799805 | null | 1 | 142 | 7.429688 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,313 | 56.71198 | 0 | male | 0 | 6 | 1,409 | COPD | COPD/CHF/Cirrhosis | 4 | 6 | under $11k | 0 | 6,969 | 4,062.6348 | null | 13 | white | 18.199219 | 18 | 0.909912 | 0.848999 | 1 | 0 | 0 | no | 0.98 | 0.95 | no dnr | 6 | 97 | 14.099609 | 70 | 30 | 36.09375 | 232 | null | null | 1 | 141 | 7.359375 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,314 | 32.58899 | 1 | male | 0 | 18 | 1,001 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $11-$25k | 0 | 40,281 | 13,931.6719 | null | 27.333328 | white | 26.097656 | 20 | 0.872925 | 0.828979 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 18 | 113 | 12.599609 | 110 | 32 | 38.69531 | 130 | null | 1 | 0.899902 | 139 | 7.379883 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,315 | 72.83496 | 1 | female | 0 | 14 | 81 | COPD | COPD/CHF/Cirrhosis | 5 | null | under $11k | 0 | 20,707 | 16,171.3594 | null | 25.333328 | hispanic | 22.898438 | 41 | 0.784912 | 0.655884 | 1 | 1 | 0 | no | 0.2 | 0.2 | no dnr | 14 | 64 | 11.798828 | 110 | 8 | 37.89844 | 248.3125 | 3.299805 | 0.399963 | 2 | 134 | 7.439453 | null | null | null | 4 | 4 | SIP>=30 | 4 |
2,316 | 93.02399 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 24,818 | 14,741.2734 | null | 39 | white | 30.597656 | 46 | 0.487976 | 0.369995 | 3 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 47 | 10.898438 | 68 | 10 | 37.89844 | 210.1875 | 3 | 1 | 2.399902 | 132 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 3.266113 |
2,317 | 52.27698 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 2 | 14 | $11-$25k | 0 | 15,833 | 5,548.2305 | null | 41 | white | 42.296875 | 70 | 0.15097 | 0.072998 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 4 | 43 | 14.199219 | 140 | 36 | 36.29688 | 145 | 1.5 | 0.399963 | 0.399963 | 141 | 7.259766 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
2,318 | 66.50195 | 1 | male | 0 | 9 | 165 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 17,841 | 9,923.0312 | null | 12 | white | 22.398438 | 20 | 0.738892 | 0.589966 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 1 | 93 | 8.599609 | 120 | 20 | 36.09375 | 142.5 | 3.899902 | 0.599976 | 0.899902 | 139 | 7.429688 | null | null | null | null | null | null | 4.425781 |
2,319 | 47.258 | 1 | male | 0 | 26 | 27 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 30,794 | 19,494.3906 | null | 8.75 | white | 17.199219 | 11 | 0.743896 | 0.47998 | 1 | 0 | 0 | metastatic | 0.5 | 0.125 | dnr after sadm | 9 | 93 | null | 110 | 20 | 37 | null | null | null | null | 140 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,320 | 75.20294 | 1 | male | 0 | 13 | 109 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | null | 0 | 15,884 | 10,151.2031 | null | 10 | white | 21.597656 | 31 | 0.80896 | 0.690918 | 1 | 1 | 0 | no | 0.99 | 0.3 | no dnr | 13 | 70 | 7.799805 | 70 | 20 | 35 | null | 3.099609 | 0.899902 | 1.5 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,321 | 47.81699 | 1 | female | 0 | 4 | 734 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 11,059 | 6,199.6445 | null | 12 | white | 7.099609 | 11 | 0.876953 | 0.7229 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 4 | 74 | 7.5 | 80 | 16 | 36.89844 | null | 4 | 0.399963 | 1 | 141 | null | null | null | null | 0 | null | SIP>=30 | 0.4948 |
2,322 | 64.29596 | 0 | female | 0 | 15 | 1,396 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 26,732 | 12,994.8281 | null | 14 | white | 18.898438 | 26 | 0.846924 | 0.794922 | 4 | 0 | 0 | no | null | null | no dnr | 15 | 55 | 7.899414 | 70 | 28 | 38.29688 | 197.5 | 3.299805 | 0.399963 | 0.599976 | 141 | 7.359375 | null | null | null | 4 | 6 | adl>=4 (>=5 if sur) | 6 |
2,323 | 62.987 | 1 | female | 0 | 14 | 19 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 35,581 | 17,470.0312 | null | 33.333313 | black | 35.695313 | 41 | 0.310974 | 0.129974 | 7 | 0 | 0 | no | 0.4 | 0.064 | dnr after sadm | 3 | 40 | 3 | 66 | 10 | 36.29688 | 219 | 2.799805 | 6.899414 | 0.699951 | 135 | 7.319336 | null | null | null | null | null | <2 mo. follow-up | 3.470215 |
2,324 | 44.42697 | 1 | female | 0 | 35 | 132 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 61 | 58,145 | 23,774 | null | 31 | black | 29.699219 | 45 | 0.577881 | 0.467957 | 1 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 28 | 130 | 15.099609 | 111 | 10 | 39.19531 | 142.5 | 2.599609 | 0.199982 | 6 | 142 | 7.479492 | null | null | null | null | 1 | null | 1 |
2,325 | 60.715 | 1 | male | 0 | 5 | 892 | Colon Cancer | Cancer | 2 | 20 | null | 0 | 4,972 | 2,736.0762 | null | 8 | white | 16 | 18 | 0.837891 | 0.643921 | 1 | 1 | 0 | metastatic | 0.99 | 0.9 | no dnr | 5 | 103 | 5.399414 | 80 | 20 | 36.09375 | null | null | null | 0.899902 | 134 | null | null | null | null | 3 | 2 | SIP>=30 | 2 |
2,326 | 20.04399 | 1 | female | 1 | 8 | 8 | Coma | Coma | 0 | null | null | 100 | 26,400 | 9,856.6875 | null | 32.5 | white | 30.597656 | 64 | 0.471985 | 0.399963 | 1 | 0 | 0 | no | null | null | no dnr | 8 | 160 | 30.699219 | 173 | 12 | 40.39844 | 217.5 | 2.899902 | 0.5 | 3 | 134 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.353027 |
2,327 | 76.38098 | 0 | male | 0 | 59 | 1,390 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 100 | 91,340 | 62,352.2188 | null | 17 | white | 23.597656 | 43 | 0.237 | 0.135986 | 10 | 1 | 0 | no | 0.9 | 0.8 | dnr after sadm | 13 | 80 | 8 | 110 | 36 | 39.39844 | 161 | null | null | 1.299805 | 145 | 7.489258 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
2,328 | 83.05298 | 0 | male | 0 | 9 | 1,387 | COPD | COPD/CHF/Cirrhosis | 3 | 19 | $11-$25k | 0 | 11,650 | 5,398.1602 | null | 17.5 | white | 21.296875 | 57 | 0.73999 | 0.590942 | 1 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 9 | 51 | 6.199219 | 53 | 16 | 36.89844 | 237.03125 | 4.099609 | 0.399963 | 2 | 142 | 7.5 | null | null | null | 0 | 0 | SIP>=30 | 0 |
2,329 | 44.42999 | 0 | male | 0 | 15 | 1,388 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 5 | under $11k | 9 | 23,510 | 12,153.7891 | null | 15.666664 | white | 18.097656 | 22 | 0.903931 | 0.868896 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 15 | 103 | 8.298828 | 68 | 24 | 38.59375 | 148 | 3.199707 | 1.799805 | 1.099854 | 145 | 7.379883 | null | null | null | 3 | null | SIP>=30 | 2.511099 |
2,330 | 74.86896 | 1 | female | 1 | 4 | 4 | Coma | Coma | 2 | 14 | null | 100 | 4,332 | 2,538.168 | null | 3 | white | 19.699219 | 37 | 0.091995 | 0.053993 | 1 | 0 | 0 | metastatic | 0.05 | 0.000125 | dnr after sadm | 1 | 123 | 12.398438 | 80 | 40 | 35.39844 | 385 | null | null | 1 | 132 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,331 | 63.77298 | 0 | male | 0 | 3 | 1,384 | COPD | COPD/CHF/Cirrhosis | 6 | 14 | under $11k | 0 | 5,000 | 2,686.8398 | null | 17 | hispanic | 14.898438 | 34 | 0.911987 | 0.851929 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 83 | 7.699219 | 104 | 30 | 36.69531 | 271.375 | 4 | 0.699951 | 1.5 | 141 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 2.956055 |
2,332 | 86.51099 | 1 | female | 0 | 7 | 15 | Coma | Coma | 1 | null | under $11k | 61 | 5,779 | 3,547.0391 | null | 4 | white | 14.699219 | 17 | 0.459961 | 0.386963 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr before sadm | -1 | 97 | 19.296875 | 70 | 20 | 38.19531 | null | null | null | 0.899902 | 138 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 |
2,333 | 76.88397 | 1 | male | 0 | 12 | 1,024 | COPD | COPD/CHF/Cirrhosis | 1 | 7 | under $11k | 0 | 19,659 | 8,682.5469 | null | 19 | other | 23.296875 | 35 | 0.750977 | 0.605957 | 1 | 0 | 0 | no | 0.4 | 0.2 | dnr before sadm | -1 | 83 | 7.899414 | 100 | 25 | 36.09375 | 150 | null | null | 1.099854 | 138 | 7.30957 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
2,334 | 73.89996 | 1 | female | 0 | 22 | 174 | Lung Cancer | Cancer | 3 | 12 | null | 0 | 32,118 | 18,400.0938 | null | 9.333328 | white | 17.199219 | 18 | 0.682983 | 0.388977 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 5 | 103 | 2.399902 | 60 | 20 | 36.09375 | null | null | null | 0.799927 | 141 | null | null | null | null | 5 | 4 | SIP>=30 | 4 |
2,335 | 41.57999 | 1 | female | 0 | 17 | 681 | MOSF w/Malig | ARF/MOSF | 1 | 18 | >$50k | 0 | 35,673 | 20,488.1875 | null | 21.333328 | white | 35.695313 | 71 | 0.35199 | 0.234985 | 1 | 0 | 0 | metastatic | 0.98 | 0.85 | no dnr | 17 | 53 | 0.099991 | 124 | 35 | 38.5 | 228 | 2.199707 | 2.899902 | 0.899902 | 145 | 7.389648 | null | null | null | 0 | 0 | SIP>=30 | 0 |
2,336 | 87.79498 | 1 | female | 0 | 12 | 716 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 13,337 | 7,492.2266 | null | 15.5 | white | 19.796875 | 49 | 0.728882 | 0.575928 | 1 | 0 | 0 | no | 0.9 | 0.75 | dnr before sadm | -1 | 117 | 4.5 | 70 | 40 | 36.09375 | 233.3125 | null | null | 1.599854 | 142 | 7.419922 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
2,337 | 23.379 | 0 | female | 0 | 10 | 1,378 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | null | 0 | 17,374 | 9,278.9297 | null | 13.5 | white | 27.398438 | 22 | 0.860962 | 0.812988 | 4 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 10 | 77 | 14.298828 | 110 | 30 | 38.89844 | 120 | 2.799805 | null | 0.799927 | 138 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,338 | 84.12897 | 1 | female | 1 | 8 | 8 | Coma | Coma | 1 | 16 | null | 100 | 23,860 | 11,709.4297 | null | 26.5 | white | 34.59375 | 50 | 0 | 0 | 7 | 0 | 0 | no | 0 | 0 | dnr after sadm | 3 | 53 | 9.298828 | 110 | 35 | 35 | 140 | 3 | null | 1.199951 | 148 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,339 | 94.26996 | 1 | female | 1 | 5 | 5 | Coma | Coma | 2 | 12 | >$50k | 100 | 5,610 | 3,407.0137 | null | 18 | white | 36 | 51 | 0 | 0 | 1 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 1 | 43 | 32.898438 | 70 | 30 | 35.59375 | 552 | 3.099609 | 0.699951 | 1.799805 | 151 | 7.609375 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
2,340 | 60.71698 | 0 | male | 0 | 25 | 1,377 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | null | 0 | 83,838 | 49,739.8125 | null | 38 | white | 26.699219 | 39 | 0.766968 | 0.691895 | 2 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 25 | 63 | 14.199219 | 67 | 28 | 38.89844 | 96.65625 | 3.699707 | 0.899902 | 1.5 | 144 | 7.419922 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,341 | 83.97797 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 37,408 | 28,155.8281 | null | 47 | white | 49.296875 | 89 | 0.048996 | 0.014999 | 6 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 33 | 15.599609 | 140 | 18 | 39.19531 | 186.65625 | 1.899902 | 1.099854 | 6.799805 | 129 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.763672 |
2,342 | 94.06195 | 1 | male | 1 | 44 | 44 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 44 | 60,663 | 31,748.0469 | null | 18 | white | 33.398438 | 53 | 0.219971 | 0.121994 | 1 | 0 | 0 | no | 0.25 | 0.1 | no dnr | 44 | 47 | 10.798828 | 59 | 28 | 36.59375 | 519 | 2.399902 | 0.699951 | 3.299805 | 145 | 7.349609 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
2,343 | 74.42798 | 1 | female | 0 | 6 | 719 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | null | 0 | 6,553 | 3,672.4277 | null | 6 | white | 20.398438 | 32 | 0.826904 | 0.718994 | 1 | 1 | 0 | no | 0.95 | 0.75 | no dnr | 6 | 73 | 5.5 | 60 | 15 | 35.59375 | 257.125 | 3.099609 | 0.599976 | 1.299805 | 143 | 7.479492 | null | null | null | null | null | no(M2 and SIP pres) | 2.177734 |
2,344 | 72.70898 | 1 | male | 0 | 19 | 1,020 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 32,712 | 22,892.3594 | null | 22 | white | 20.796875 | 32 | 0.802979 | 0.682983 | 2 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 19 | 105 | 11.398438 | 81 | 10 | 38.19531 | 150 | 3.799805 | 0.599976 | 2 | 133 | 7.449219 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
2,345 | 76.849 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 9 | 43,883 | 32,881.8125 | null | 32 | white | 23.398438 | 39 | 0.61499 | 0.509888 | 9 | 0 | 1 | yes | 0.1 | 0.001 | dnr after sadm | 6 | 57 | 12.699219 | 80 | 28 | 38.69531 | 157.125 | null | null | 0.699951 | 138 | 7.479492 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
2,346 | 76.435 | 1 | male | 0 | 11 | 472 | CHF | COPD/CHF/Cirrhosis | 6 | 12 | under $11k | 0 | 12,933 | 6,387.9922 | null | 14.5 | white | 33.5 | 55 | 0.482971 | 0.280945 | 1 | 1 | 0 | yes | 0.8 | 0.5 | dnr before sadm | -1 | 53 | 10.199219 | 70 | 25 | 36.09375 | 113.32812 | null | null | 2.299805 | 137 | 7.369141 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,347 | 77.74896 | 1 | male | 0 | 26 | 328 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 37,301 | 18,901.2188 | null | 21 | white | 34.796875 | 53 | 0.518921 | 0.402954 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 26 | 60 | 21.296875 | 140 | 12 | 36.39844 | 143.75 | null | null | 3.399902 | 147 | 7.459961 | null | null | null | null | null | no(M2 and SIP pres) | 3.675293 |
2,348 | 24.36699 | 1 | male | 1 | 9 | 9 | Coma | Coma | 0 | 16 | null | 100 | 32,558 | 21,909.3125 | null | 41 | white | 22.699219 | 30 | 0.638916 | 0.577881 | 1 | 0 | 0 | no | 0.9 | 0.9 | dnr after sadm | 8 | 125 | 5.099609 | 150 | 14 | 39.39844 | 196 | 2.5 | 0.599976 | 0.699951 | 145 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,349 | 33.33899 | 0 | female | 0 | 8 | 1,371 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | $11-$25k | 0 | 9,397 | 4,952.1719 | null | 12 | hispanic | 16.199219 | 16 | 0.939941 | 0.917969 | 1 | 1 | 0 | no | 0.99 | 0.99 | no dnr | 8 | 83 | 7 | 70 | 20 | 36.09375 | 300 | 3.299805 | 1 | 0.899902 | 135 | 7.469727 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,350 | 67.948 | 0 | female | 0 | 3 | 1,369 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 3,707 | 2,003.1494 | null | 19 | white | 8.699219 | 11 | 0.938965 | 0.894897 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 3 | 80 | 6.699219 | 70 | 20 | 37.39844 | 240 | 4.299805 | null | 1.099854 | 144 | 7.40918 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,351 | 78.38495 | 0 | female | 0 | 42 | 1,369 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 37 | 55,119 | 31,046.0312 | null | 13.5 | white | 24.898438 | 37 | 0.602905 | 0.495972 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 3 | 61 | 11.5 | 55 | 12 | 36.09375 | 486.1875 | 2.899902 | 0.5 | 1.899902 | 148 | 7.369141 | null | null | null | null | null | null | 3.239258 |
2,352 | 70.00696 | 0 | female | 0 | 33 | 1,368 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 52,072 | 24,351.1875 | null | 21.25 | white | 28.398438 | 65 | 0.650879 | 0.55188 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 33 | 44 | 37.898438 | 78 | 40 | 38.59375 | 228.5625 | 1.899902 | 1.299805 | 1.399902 | 139 | 7.339844 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
2,353 | 85.85394 | 1 | female | 0 | 13 | 48 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 9 | 16,619 | 9,151.375 | null | 14.5 | white | 31.5 | 43 | 0.511963 | 0.395996 | 1 | 1 | 0 | no | 0.7 | 0.7 | no dnr | 13 | 53 | 4.199219 | 70 | 30 | 36.69531 | 105 | null | null | 0.899902 | 142 | 7.349609 | null | null | null | 2 | 5 | <2 mo. follow-up | 5 |
2,354 | 95.50995 | 1 | male | 1 | 8 | 8 | Coma | Coma | 1 | 15 | $11-$25k | 0 | 8,418 | 4,959.6328 | null | 14 | white | 21.199219 | 29 | 0.403992 | 0.329956 | 1 | 0 | 0 | yes | 0.01 | 0.000001 | dnr before sadm | -1 | 83 | 34.796875 | 100 | 30 | 38.59375 | null | 4.199219 | 1.099854 | 1.399902 | 136 | null | null | null | null | null | 3 | <2 mo. follow-up | 3 |
2,355 | 61.57199 | 0 | female | 0 | 13 | 1,367 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 17,562 | 9,151.3125 | null | 18.5 | white | 17.296875 | 36 | 0.889893 | 0.850952 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 13 | 53 | 8 | 69 | 30 | 38.79688 | 264 | 3.199707 | 0.399963 | 0.899902 | 139 | 7.469727 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
2,356 | 76.67096 | 1 | male | 1 | 26 | 26 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 9 | 28,454 | 17,808.5312 | null | 14.75 | white | 16.199219 | 22 | 0.850952 | 0.754883 | 1 | 0 | 0 | no | 0.9 | 0.75 | dnr after sadm | 10 | 73 | 8.398438 | 76 | 24 | 36.59375 | null | 3.299805 | 1.5 | 1.299805 | 136 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
2,357 | 65.88599 | 1 | male | 1 | 25 | 25 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 50,062 | 30,376.6094 | null | 29.333328 | white | 31.097656 | 55 | 0.678955 | 0.584961 | 1 | 0 | 0 | no | 0.5 | 0.7 | dnr after sadm | 19 | 45 | 11 | 72 | 38 | 38.5 | 244.4375 | 2.699707 | 1.099854 | 2.5 | 141 | 7.40918 | null | null | null | 3 | 3 | <2 mo. follow-up | 3 |
2,358 | 80.27698 | 0 | female | 0 | 4 | 1,362 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 4,464 | 2,597.1328 | null | 13 | white | 18.898438 | 21 | 0.797974 | 0.67395 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 4 | 107 | 11.398438 | 60 | 20 | 35.59375 | 332 | null | null | 1 | 140 | 7.359375 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
2,359 | 80.47095 | 0 | male | 0 | 9 | 1,361 | CHF | COPD/CHF/Cirrhosis | 3 | 19 | under $11k | 0 | 10,981 | 5,523.8789 | null | 5 | white | 14.099609 | 21 | 0.87793 | 0.796997 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 9 | 83 | 7 | 60 | 15 | 36.69531 | 410 | 4 | 0.5 | 1.699951 | 138 | 7.459961 | null | null | null | 6 | 1 | no(M2 and SIP pres) | 1 |
2,360 | 85.06494 | 0 | male | 0 | 17 | 1,359 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 5 | $11-$25k | 44 | 21,711 | 11,713.5469 | null | 17 | white | 20.398438 | 35 | 0.641968 | 0.540894 | 1 | 0 | 1 | no | 0.15 | 0.05 | dnr after sadm | 5 | 113 | 5.899414 | 110 | 30 | 38.09375 | 306.625 | 2.199707 | 1.899902 | 0.899902 | 144 | 7.419922 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
2,361 | 78.32196 | 1 | male | 0 | 12 | 1,201 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 16,940 | 8,582.7422 | null | 16 | white | 28.199219 | 46 | 0.637939 | 0.45697 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 12 | 128 | 12.5 | 59 | 36 | 37.09375 | 172.5 | 3.399902 | 0.299988 | 3.399902 | 138 | 7.419922 | null | null | null | 0 | 0 | SIP>=30 | 0 |
2,362 | 52.26797 | 1 | female | 0 | 4 | 11 | Lung Cancer | Cancer | 1 | null | under $11k | 0 | 3,133 | 1,922.8633 | null | 2 | white | 21.097656 | 6 | 0.653931 | 0.348999 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 83 | 11.398438 | 100 | 20 | 36.09375 | null | 3.299805 | 0.5 | 0.799927 | 138 | null | null | null | null | null | null | <2 mo. follow-up | 2.172363 |
2,363 | 50.20898 | 1 | female | 0 | 14 | 108 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 17,041 | 10,160.3672 | null | 5.333332 | white | 4.299805 | 9 | 0.898926 | 0.766968 | 1 | 0 | 0 | metastatic | 0.9 | 0.09 | dnr after sadm | 6 | 80 | 9.5 | 72 | 20 | 36.79688 | null | 4.699219 | 0.399963 | 0.5 | 135 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
2,364 | 63.228 | 1 | male | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 1 | 16 | >$50k | 0 | 33,619 | 13,934.8281 | null | 50.5 | white | 42.09375 | 65 | 0.211975 | 0.116989 | 1 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 8 | 53 | 2.899902 | 56 | 12 | 38.39844 | 63 | 3 | 2.199707 | 3.399902 | 138 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,365 | 68.58899 | 1 | male | 0 | 13 | 692 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 17 | $25-$50k | 0 | 52,123 | 13,483.3047 | null | 17 | white | 16.398438 | 24 | 0.882935 | 0.841919 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 13 | 70 | 15.199219 | 70 | 22 | 38.5 | 484 | 3.399902 | 0.899902 | 1.5 | 136 | 7.439453 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,366 | 79.06897 | 1 | female | 0 | 10 | 114 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | null | 0 | 12,777 | 7,161.125 | null | 9.5 | white | 15.099609 | 17 | 0.872925 | 0.78894 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 10 | 87 | 11.398438 | 80 | 20 | 36.69531 | 271.375 | null | null | 1.199951 | 141 | 7.419922 | null | null | null | 3 | 0 | no(M2 and SIP pres) | 0 |
2,367 | 83.39996 | 1 | male | 0 | 50 | 90 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 9 | 61,748 | 37,880.6562 | null | 10.75 | white | 32.695313 | 49 | 0.493958 | 0.375977 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 16 | 73 | 4.899414 | 137 | 40 | 36.09375 | null | 3.299805 | 1.399902 | 2.299805 | 150 | 7.449219 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
2,368 | 33.922 | 1 | male | 0 | 17 | 299 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 9 | 25,613 | 10,798.6406 | null | 17.333328 | white | 26.5 | 44 | 0.848999 | 0.796997 | 1 | 0 | 0 | no | 0.7 | 0.4 | no dnr | 17 | 65 | 16.5 | 130 | 24 | 38.09375 | 284 | 2.299805 | 8.298828 | 0.799927 | 141 | 7.549805 | null | null | null | null | null | null | 2.770508 |
2,369 | 63.29398 | 1 | male | 0 | 11 | 498 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 19 | null | 0 | 21,501 | 10,837.3281 | null | 27 | white | 22.699219 | 40 | 0.829956 | 0.772949 | 1 | 1 | 0 | no | 0.7 | 0.6 | no dnr | 11 | 63 | 5.599609 | 80 | 14 | 36.79688 | 207.5 | 2.799805 | 0.5 | 5.899414 | 135 | 7.359375 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,370 | 96.42694 | 1 | female | 0 | 5 | 1,050 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 5,218 | 3,066.8047 | null | 15 | white | 16.796875 | 20 | 0.716919 | 0.559937 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 103 | 14.199219 | 80 | 20 | 36.69531 | 251.65625 | null | 1.299805 | 1.399902 | 144 | 7.329102 | null | null | null | null | null | no(M2 and SIP pres) | 3.303711 |
2,371 | 69.43994 | 1 | male | 1 | 5 | 5 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 18,031 | 7,176.5977 | null | 34 | white | 33.296875 | 48 | 0.55188 | 0.353943 | 4 | 0 | 0 | no | 0.09 | 0.000729 | no dnr | 5 | 50 | 26 | 105 | 24 | 38 | 118.875 | null | null | 1.599854 | 136 | 7.259766 | null | null | null | null | null | <2 mo. follow-up | 2.71582 |
2,372 | 63.625 | 0 | female | 0 | 8 | 1,349 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 9 | 11,290 | 5,561.3125 | null | 9 | white | 16.796875 | 9 | 0.885986 | 0.80896 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 1 | 93 | 8.599609 | 100 | 20 | 36.69531 | 344.4375 | null | null | 0.799927 | 142 | 7.319336 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,373 | 69.30597 | 0 | male | 0 | 15 | 1,349 | Coma | Coma | 1 | 8 | $11-$25k | 100 | 28,125 | 19,160.1094 | null | 15.666664 | black | 26.597656 | 49 | 0.060997 | 0.032997 | 1 | 0 | 0 | yes | 0.05 | 0.000125 | no dnr | 15 | 74 | 10.5 | 74 | 42 | 36.39844 | 124 | 3.399902 | 2.199707 | 1.5 | 138 | 7.459961 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,374 | 85.51996 | 1 | male | 0 | 8 | 349 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 8 | null | 0 | 10,072 | 5,087.5469 | null | 12 | white | 20.199219 | 37 | 0.685913 | 0.592896 | 1 | 1 | 0 | metastatic | 0.9 | 0.8 | no dnr | 8 | 61 | 14.798828 | 58 | 30 | 36.09375 | 314.25 | 3.099609 | null | 1.099854 | 140 | 7.489258 | null | null | null | 1 | 0 | null | 0 |
2,375 | 81.44299 | 0 | female | 0 | 16 | 1,347 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 9 | 52,123 | 35,130.2812 | null | 24.666656 | white | 22.898438 | 29 | 0.598999 | 0.490967 | 9 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 9 | 61 | 15 | 69 | 24 | 38.29688 | 106.65625 | 2.699707 | 0.699951 | 1.399902 | 135 | 7.509766 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,376 | 75.44098 | 0 | female | 0 | 9 | 1,344 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 16 | $25-$50k | 0 | 17,626 | 7,756.8359 | null | 13.5 | black | 29.796875 | 35 | 0.542969 | 0.428955 | 3 | 1 | 0 | yes | 0.95 | 0.93 | no dnr | 9 | 69 | 10.898438 | 70 | 14 | 36.19531 | 128 | 3.299805 | 1.299805 | 3.699707 | 141 | 7.449219 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,377 | 63.978 | 1 | female | 0 | 35 | 269 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 79,417 | 48,618.5312 | null | 27 | white | 21.5 | 40 | 0.789917 | 0.721924 | 14 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 35 | 77 | 16.5 | 80 | 4 | 36.39844 | 268 | null | null | 0.699951 | 139 | 7.389648 | null | null | null | 2 | 1 | no(M2 and SIP pres) | 1 |
2,378 | 38.80399 | 1 | male | 0 | 3 | 115 | Colon Cancer | Cancer | 1 | 10 | $25-$50k | 0 | 4,218 | 2,412.7617 | null | 12 | white | 17.796875 | 18 | 0.850952 | 0.669922 | 1 | 0 | 0 | metastatic | 0.9 | 0.9 | no dnr | 3 | 99 | null | 120 | 26 | 37.89844 | null | 3.599609 | 0.899902 | 0.699951 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.734375 |
2,379 | 72.40497 | 1 | female | 0 | 10 | 761 | MOSF w/Malig | ARF/MOSF | 5 | 12 | null | 0 | 16,955 | 6,938.1562 | null | 15 | white | 16 | 35 | 0.821899 | 0.761963 | 1 | 1 | 0 | yes | 0.98 | 0.8 | no dnr | 10 | 113 | 93.890625 | 85 | 34 | 38.09375 | 232.25 | 4.199219 | 0.199982 | 0.899902 | 140 | 7.359375 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,380 | 72.10095 | 1 | male | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 1 | 16 | null | 0 | 29,317 | 17,072.7812 | null | 25 | white | 26 | 37 | 0.60498 | 0.497986 | 3 | 0 | 0 | yes | 0.01 | 0.000001 | dnr after sadm | 1 | 100 | 63 | 80 | 32 | 35.69531 | 161.21875 | null | null | 1.5 | 146 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,381 | 80.27399 | 1 | male | 0 | 8 | 303 | Colon Cancer | Cancer | 2 | 16 | >$50k | 0 | 7,562 | 4,552.8359 | null | 2.5 | white | 13.699219 | 14 | 0.832886 | 0.635986 | 1 | 0 | 0 | metastatic | 0.98 | 0.8 | no dnr | 8 | 97 | 4.599609 | 80 | 20 | 36.69531 | null | null | null | 1.199951 | 140 | null | null | null | null | 3 | 1 | no(M2 and SIP pres) | 1 |
2,382 | 67.03595 | 1 | male | 1 | 8 | 8 | Colon Cancer | Cancer | 1 | 8 | under $11k | 0 | 16,195 | 9,882.6484 | null | 24 | white | 39.5 | 44 | 0.27594 | 0.040993 | 1 | 0 | 0 | metastatic | 0.2 | 0.02 | dnr after sadm | 7 | 117 | 19.597656 | 110 | 30 | 35.69531 | 316.3125 | 2.699707 | 9.5 | 1.299805 | 136 | 7.40918 | null | null | null | 3 | 1 | <2 mo. follow-up | 1 |
2,383 | 43.66098 | 1 | male | 0 | 11 | 282 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | under $11k | 0 | 19,138 | 9,625.2031 | null | 10.5 | white | 22.5 | 38 | 0.866943 | 0.819946 | 3 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 11 | 133 | 5.299805 | 80 | 20 | 36.69531 | null | 2.199707 | null | 5.299805 | 136 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,384 | 66.04498 | 1 | male | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 16 | null | 0 | 11,598 | 3,684.0996 | null | 52 | white | 61 | 91 | 0 | 0 | 1 | 1 | 0 | metastatic | 0 | 0 | dnr after sadm | 3 | 33 | 23.796875 | 40 | 44 | 36.39844 | 105 | 2.199707 | 2.199707 | 4.199219 | 127 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.175293 |
2,385 | 83.06396 | 1 | male | 0 | 12 | 65 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 17,204 | 10,102.1719 | null | 13.5 | white | 27.097656 | 44 | 0.344971 | 0.155975 | 1 | 0 | 0 | yes | 0.5 | 0.33 | dnr after sadm | 4 | 68 | 13.298828 | 60 | 20 | 35.59375 | null | null | 2 | 2.299805 | 131 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,386 | 89.67297 | 1 | female | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 3 | 30 | $25-$50k | 9 | 19,612 | 5,866.1602 | null | 29 | white | 26.398438 | 44 | 0.539917 | 0.425964 | 2 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 1 | 120 | 19.398438 | 78 | 28 | 37.89844 | 170 | null | 0.899902 | 4.199219 | 136 | 7.389648 | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
2,387 | 84.51996 | 1 | female | 0 | 5 | 1,244 | CHF | COPD/CHF/Cirrhosis | 4 | 13 | $11-$25k | 0 | 5,884 | 4,059.6016 | null | 10 | white | 19.398438 | 30 | 0.756958 | 0.61499 | 1 | 0 | 0 | yes | 0.95 | 0.95 | no dnr | 5 | 117 | 9.298828 | 45 | 28 | 36.69531 | 223.3125 | 3.199707 | 0.399963 | 1.199951 | 143 | 7.369141 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,388 | 71.88794 | 1 | male | 0 | 6 | 243 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | null | 0 | 4,909 | 3,153.375 | null | 14 | white | 22.097656 | 34 | 0.814941 | 0.699951 | 1 | 1 | 0 | no | 0.98 | 0.95 | no dnr | 6 | 83 | 5.399414 | 70 | 20 | 35.59375 | null | null | null | 2.199707 | 133 | null | null | null | null | 5 | null | SIP>=30 | 3.855299 |
2,389 | 75.67395 | 1 | female | 0 | 47 | 54 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 61,867 | 35,709 | null | 18.25 | white | 36.398438 | 68 | 0.487 | 0.368958 | 1 | 0 | 0 | no | 0.75 | 0.6 | dnr after sadm | 3 | 45 | 25.199219 | 160 | 48 | 39.29688 | 342.8125 | 2.5 | 0.799927 | 1.899902 | 142 | 7.269531 | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
2,390 | 100.13098 | 1 | female | 0 | 5 | 1,082 | CHF | COPD/CHF/Cirrhosis | 3 | 4 | null | 0 | 4,485 | 2,759.3106 | null | 6 | black | 15.199219 | 23 | 0.755981 | 0.613892 | 1 | 0 | 0 | yes | 0.7 | 0.6 | no dnr | 5 | 77 | 6 | 60 | 15 | 36.09375 | null | 3.699707 | null | 1.099854 | 141 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.382324 |
2,391 | 41.771 | 1 | male | 1 | 21 | 21 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 14 | null | 0 | 97,144 | 72,525.5625 | null | 44.333313 | hispanic | 24.097656 | 37 | 0.826904 | 0.718994 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 20 | 70 | 11.199219 | 70 | 10 | 38.09375 | 162 | 1.699951 | 5.5 | 0.799927 | 132 | 7.449219 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,392 | 54.36798 | 0 | male | 0 | 14 | 1,324 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 35,856 | 23,739.0781 | null | 31.333328 | white | 30.699219 | 64 | 0.699951 | 0.609985 | 4 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 14 | 61 | 7.599609 | 150 | 52 | 39.29688 | 102.5 | 2.5 | 0.399963 | 1.199951 | 134 | 7.229492 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,393 | 71.43896 | 1 | female | 0 | 19 | 34 | COPD | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 25,724 | 12,041.1484 | null | 18.333328 | white | 21.597656 | 30 | 0.767944 | 0.630981 | 1 | 0 | 0 | yes | 0.6 | 0.5 | dnr after sadm | 7 | 100 | 12.298828 | 100 | 15 | 36.09375 | 355 | 3.799805 | 0.299988 | 2.599609 | 141 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,394 | 66.10297 | 0 | male | 0 | 4 | 1,321 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 6,726 | 2,813.3965 | null | 15 | white | 18.898438 | 32 | 0.870972 | 0.785889 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 63 | 10.798828 | 54 | 14 | 36.29688 | 219.03125 | null | 1.399902 | 1.099854 | 142 | 7.379883 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,395 | 72.30096 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 9 | null | 0 | 63,943 | 28,989.6094 | null | 48.5 | black | 37.5 | 74 | 0.362 | 0.244995 | 15 | 1 | 0 | no | null | null | dnr after sadm | 9 | 63 | 30.097656 | 119 | 38 | 35.19531 | 151.65625 | 2.199707 | 1 | 7.799805 | 132 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,396 | 72.81 | 1 | female | 1 | 10 | 10 | Coma | Coma | 4 | 12 | under $11k | 61 | 20,721 | 7,335.1953 | null | 31.5 | white | 38.59375 | 60 | 0.025997 | 0.011 | 1 | 1 | 1 | no | 0.1 | 0.001 | dnr after sadm | 9 | 43 | 22.398438 | 120 | 28 | 38.69531 | 324.4375 | 2.199707 | null | 3.699707 | 142 | 7.379883 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
2,397 | 75.258 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 34,405 | 13,343.0625 | null | 42.5 | white | 34.5 | 36 | 0.386963 | 0.267944 | 5 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 5 | 44 | 21.398438 | 108 | 16 | 38.19531 | 135 | null | null | 1.199951 | 145 | 7.399414 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,398 | 74.72699 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 35,196 | 12,690.6484 | null | 40.5 | white | 38.195313 | 70 | 0.366943 | 0.248993 | 5 | 1 | 0 | no | 0.2 | 0.2 | dnr after sadm | 2 | 49 | 14.298828 | 120 | 34 | 38.29688 | 148.3125 | 2.899902 | 0.199982 | 3.399902 | 136 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 2.500488 |
2,399 | 66.97095 | 0 | female | 0 | 18 | 1,315 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 26,628 | 12,572.0234 | null | 12 | white | 18.796875 | 18 | 0.868896 | 0.781982 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 18 | 62 | 8.398438 | 110 | 8 | 37.89844 | 162.5 | 3.799805 | 0.899902 | 0.899902 | 143 | 7.349609 | null | null | null | 3 | 4 | no(M2 and SIP pres) | 4 |
2,400 | 87.86298 | 0 | female | 0 | 15 | 1,314 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 28,359 | 18,643.0156 | null | 15.333328 | white | 33.5 | 63 | 0.458984 | 0.338989 | 2 | 0 | 0 | no | 0.85 | 0.5 | dnr before sadm | -1 | 53 | 5.199219 | 66 | 36 | 35.59375 | 188 | 3.599609 | 0.799927 | 7.199219 | 137 | 7.329102 | null | null | null | 4 | null | no(M2 and SIP pres) | 3.183199 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.